1. Besednova, N.N., Andryukov, B.G., Zaporozhets, T.S., et al., Enveloped viruses: Pathogenetic targets for cyanobacterial lectins, Antibiot. Khimioter., 2022, vol. 67, nos. 5−6, pp. 39−60.
2. Breslav, N.V., Shevchenko, E.S., Abramov, D.D., et al., Efficacy of anti-neuraminidase drugs application during and after an influenza pandemic, Vopr. Virusol., 2013, vol. 58, no. 1, pp. 28−32.
3. Kolobukhina, L.V., Merkulova, L.N., Malyshev, N.A., et al., A strategy of early antiviral therapy of influenza could prevent severe complications, Pulmonologiya, 2010, no. 1, pp. 9−14.
4. Kolobukhina, L.V., Merkulova, L.N., Shchelkanov, M.Yu., et al., Pandemic flu in Russia: Special features of a clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease, Ter. Arkh., 2011, vol. 83, no. 9, pp. 48–53.
5. Krylova, N.V., Smolina, T.P., Berlizova, M.V., and Leonova, G.N., Immunocorrective and antiviral activity of polysaccharide from marine bacteria against tick-borne encephalitis virus, Antibiot. Khimioter., 2019, vol. 64, nos. 11–12, pp. 16–24.